ArticleTrials2026
Assessment of a new unidirectional barbed suture versus a conventional suture for anastomosis during robotic-assisted Roux-en-Y gastric bypass surgery in obese patients: BARGASTRO - study protocol for a German randomized active-controlled trial.
Article in Trials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05433688 (Prospective, Mono-center, Randomized, Single-blinded, Controlled Study on the Performance of Symmcora® Mid-term Suture Versus Novosyn® Suture in Patients Undergoing Robotic Assisted Gastric Bypass Surgery), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Prospective, Mono-center, Randomized, Single-blinded, Controlled Study on the Performance of Symmcora® Mid-term Suture Versus Novosyn® Suture in Patients Undergoing Robotic Assisted Gastric Bypass Surgery
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGastric bypass surgery is an efficient surgical intervention for the treatment of obese patients. The procedure can be performed either laparoscopically or robotic assisted. To simplify the intracorporeal handling of the suture material in a bi- or tri-dimensional plane, a new generation of sutures, named barbed sutures, has been developed recently and is being used for different indications. Barbed sutures allow knotless slippage-resistant suturing due to the self-anchoring elements distributed along the thread length and therefore obviate the need for assistance. Their safety and efficacy have been demonstrated in several meta-analyses and systematic reviews. In the present study, the clinical performance of a new unidirectional barbed suture material, which differs in regard to its configuration from other barbed suture materials, is analysed and compared to a conventional suture material in robotic-assisted gastric bypass surgery to treat morbid obesity.
methodsThe study will be performed as an industry-sponsored, mono-centre, randomized, active-controlled, two-arm, parallel-group, superiority trial. A total of 150 patients will be randomly allocated to both suture types in a 1:1 ratio. The suture material will be used to construct the gastro-jejunal anastomosis as well as the jejuno-jejunal anastomosis. The time needed to create both anastomoses is the primary endpoint. Intraoperative handling of both suture materials, patient satisfaction, pain, and complications occurring during the study will serve as secondary outcomes. Furthermore, the difference in quality of life using two different questionnaires (EQ5D5L and Bariatric Analysis and Reporting Outcome System (BAROS)) will be assessed preoperatively and postoperatively (30 days and 12 months) and will be compared between the suture groups as well as over time. The EQ-5D-5L questionnaire consists of five dimensions (mobility, self-care, usual activities, pain or discomfort, anxiety or depression) and a visual analogue scale (VAS) to record the patient's health status. The BAROS evaluates three sub-categories: The percentage of excess weight loss, the changes in medical conditions, and quality of life, leading to three individual sub-scores, which are added to the final total score defining the failure or success of treatment. The follow-up period is 1 year after surgery. DISCUSSION: To our knowledge, the BARGASTRO study will be the largest randomized controlled trial investigating a barbed suture versus a conventional one in robotic-assisted gastric bypass surgery to treat obese patients. The study will provide and report clinical data on evidence level Ib.
trial registrationNCT05433688. Registered on 12 Oct. 2022.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.